PHILADELPHIA--(BUSINESS WIRE)--Revitas, Inc., the leading provider of integrated solutions for contract, revenue, and compliance management, today announced that Amneal Pharmaceuticals (Amneal), one of the largest generic drug suppliers in the U.S., has selected the Revitas suite of revenue management solutions to support global growth and meet expanded business requirements. The suite of revenue management applications will be delivered on the strategic and standards-based Revitas® Flex® technology platform.
The implementation will provide Amneal with a robust, efficient, and cost-effective suite of commercial and government contracting applications for optimal operational performance and efficiency, and improved reporting capabilities.
“We are happy to be working with Amneal to deliver a solution to support its business objectives for revenue management, now and in the future,” said Brian Madocks, CEO and President of Revitas. “The generics segment of the pharmaceutical market in the U.S. is still experiencing unprecedented, rapid growth. The revenue management and compliance suite, powered by the Revitas Flex platform, will help Amneal to streamline processes to gain competitive edge.”
For more information, visit the Revitas website at www.revitasinc.com.
Revitas accelerates revenue by delivering comprehensive, integrated solutions for contract, revenue, and compliance management. Revitas enables channel-driven companies to create, execute, and manage complex contracts and incentives effectively and profitably, both on premise and in the cloud. Powered by the secure, scalable, and standards-based Flex® platform, Revitas® solutions interoperate with core business systems including CRM, CPQ, and ERP, extending the functional reach and maximizing the value of the enterprise applications ecosystem. For over 25 years, Revitas has empowered companies in world’s most challenging and highly regulated industries to boost total revenue, optimize profitability, and ensure regulatory and financial compliance. Learn more about Revitas by visiting www.revitasinc.com or http://blog.revitasinc.com.